And the Transdisciplinary Outpatient Clinic for Gender Identity and Sexual Orientation at the Institute of Psychiatry in São Paulo.
Due to increasing safety concerns, puberty blockers have been permanently prohibited in the UK for youngsters seeking gender-affirming therapy.
According to a study published by the Commission on Human Medicines (CHM), there is “currently an unacceptable safety risk in the continued prescription of puberty blockers to children.”
In order to guarantee the safety of young individuals going through medical transition, the panel has suggested indefinite limits until further study is done.
In his remarks, Health and Social Care Secretary Wes Streeting stressed the need to “act with caution” and “follow the expert advice” when dealing with this “vulnerable group of young people.”
